Lesley Stafford1, Michael Berk, Prasuna Reddy, Henry J Jackson. 1. Department of Psychology, School of Behavioural Science, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria, Australia. lesley.liebowitz@bigpond.com
Abstract
OBJECTIVE: This article reviews recent studies relating to the impact of depression and its treatment on the health-related quality of life (HRQOL) of patients with coronary artery disease (CAD). METHODS: Articles for the primary review were identified via MEDLINE and PsycINFO (1995-2006). RESULTS: Evidence suggests that depression has an aversive impact on the HRQOL of patients with stable CAD as well as on patients hospitalized for acute myocardial infarction and coronary artery bypass graft surgery. Unfortunately, there are few depression treatment studies in patients with CAD that make use of standardized HRQOL measures, but the limited evidence suggests that successful treatment has positive implications for HRQOL in these patients. The mechanisms through which depression impacts on HRQOL require further study but are likely to be behavioral. CONCLUSIONS: Depressive symptoms significantly undermine HRQOL in patients with CAD despite successful medical and surgical management. Although successful treatment of depression has not been shown to reduce mortality rates in patients with CAD, further study may find that the HRQOL benefits of such treatment are equally valuable.
OBJECTIVE: This article reviews recent studies relating to the impact of depression and its treatment on the health-related quality of life (HRQOL) of patients with coronary artery disease (CAD). METHODS: Articles for the primary review were identified via MEDLINE and PsycINFO (1995-2006). RESULTS: Evidence suggests that depression has an aversive impact on the HRQOL of patients with stable CAD as well as on patients hospitalized for acute myocardial infarction and coronary artery bypass graft surgery. Unfortunately, there are few depression treatment studies in patients with CAD that make use of standardized HRQOL measures, but the limited evidence suggests that successful treatment has positive implications for HRQOL in these patients. The mechanisms through which depression impacts on HRQOL require further study but are likely to be behavioral. CONCLUSIONS:Depressive symptoms significantly undermine HRQOL in patients with CAD despite successful medical and surgical management. Although successful treatment of depression has not been shown to reduce mortality rates in patients with CAD, further study may find that the HRQOL benefits of such treatment are equally valuable.
Authors: A S Boureau; J N Trochu; A Rouaud; R Hureau; P Jaafar; T Manigold; V Letocart; P Guerin; G Berrut; L de Decker Journal: J Nutr Health Aging Date: 2017 Impact factor: 4.075
Authors: John W Liang; Ying Kuen Cheung; Joshua Z Willey; Yeseon P Moon; Ralph L Sacco; Mitchell S V Elkind; Mandip S Dhamoon Journal: Qual Life Res Date: 2017-03-29 Impact factor: 4.147
Authors: Katherine C Barboza; Lilian M Salinas; Farhad Sahebjam; Arun B Jesudian; Ilan L Weisberg; Samuel H Sigal Journal: Metab Brain Dis Date: 2016-03-31 Impact factor: 3.584
Authors: André Tylee; Mark Haddad; Elizabeth Barley; Mark Ashworth; June Brown; John Chambers; Anne Farmer; Zoe Fortune; Rebecca Lawton; Morven Leese; Anthony Mann; Paul McCrone; Joanna Murray; Carmine Pariante; Rachel Phillips; Diana Rose; Gill Rowlands; Ramon Sabes-Figuera; Alison Smith; Paul Walters Journal: BMC Psychiatry Date: 2012-06-06 Impact factor: 3.630
Authors: Adrienne O'Neil; Christopher E Stevenson; Emily D Williams; Duncan Mortimer; Brian Oldenburg; Kristy Sanderson Journal: Qual Life Res Date: 2012-02-10 Impact factor: 4.147